← Banking With Billy News

$TVRD πŸš€ +37% AH πŸ”ΉοΈ Tvardi Therapeutics is a clinical-stage biotech focused on STAT3 inhibitors for cancer, fibrosis + inflammatory diseases πŸ’Š πŸ”ΉοΈ Big after-h

Breakout Stocks β€’ 2026-06-26 20:40 UTC β€’ By Billy Odell Tucker-Robinson
$TVRD πŸš€ +37% AH
πŸ”ΉοΈ Tvardi Therapeutics is a clinical-stage biotech focused on STAT3 inhibitors for cancer, fibrosis + inflammatory diseases πŸ’Š
πŸ”ΉοΈ Big after-h
$TVRD πŸš€ +37% AH πŸ”ΉοΈ Tvardi Therapeutics is a clinical-stage biotech focused on STAT3 inhibitors for cancer, fibrosis + inflammatory diseases πŸ’Š πŸ”ΉοΈ Big after-hours move bringing fresh attention back to the name πŸ‘€ πŸ”ΉοΈ Biotech momentum can move fast when news + volume hit together ⚑ πŸ”ΉοΈ Traders watc…
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network β€” bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y β€’ YouTube: @BankingWithBilly